Australia lags in down-scheduling and misses its benefits

Australia lags internationally when it comes to down-scheduling medicines; leading New Zealand pharmacist Natalie Gauld explores why, and how the Australian pharmacy landscape could benefit from increasing access to drugs and vaccines. Australia has fallen a little behind the UK and NZ in down-scheduling medicines from prescription to non-prescription.[1] Qualitative research has found that a